Author:
Javelaud Delphine,Mauviel Alain
Reference117 articles.
1. Albino AP, Davis BM, Nanus DM (1991) Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 51:4815–4820
2. Alexaki VI, Javelaud D, Van Kempen LC et al (2010) GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst 102:1148–1159
3. Altomonte M, Montagner R, Fonsatti E et al (1996) Expression and structural features of endoglin (CD105), a transforming growth factor β1 and β3 binding protein, in human melanoma. Br J Cancer 74:1586–1591
4. Arteaga CL, Hurd SD, Winnier AR et al (1993) Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J Clin Invest 92:2569–2576
5. Berking C, Takemoto R, Schaider H et al (2001) Transforming growth factor-β1 increases survival of human melanoma through stroma remodeling. Cancer Res 61:8306–8316